Without further ado, let’s get started.
Earlier this week, Canopy Growth (TSX: WEED) (NYSE: CGC) announced it struck a deal to purchase a 72% majority stake in Biosteel Sports Nutrition.
Team BioSteel members include some of the best former and current athletes around such as Wayne Gretzky, Connor McDavid, Tyler Seguin, Ezekiel Elliott, Andrew Wiggins, Vladimir Guerrero Jr. and Brooke Henderson.
Former Wall Street bankers from Deutsche Bank and JPMorgan have big plans to launch new funds geared towards taking advantage of battered marijuana stocks.
“We love messy, choppy markets. I think the current duress in the public markets will be good for us.”
Constellation Brands (NYSE: STZ) reported its fiscal Q2 2020 financial results beating Wall Street’s expectations on revenue and adjusted earnings per share (EPS).
However, Canopy Growth’s (TSX: WEED) (NYSE: CGC) millions in losses continue to weigh heavily on the alcohol giant.
Companies like Canopy Growth (TSX: WEED) (NYSE: CGC), Aurora Cannabis (TSX: ACB) (NYSE: ACB), GW Pharma (NASDAQ: GWPH) and Cronos Group (TSX: CRON) (NASDAQ: CRON) currently lead the pack in terms of largest short positions.
As shorts continue to pile in and regulatory issues fade, the potential for a massive short squeeze is heightened.
This industrywide bloodbath, though, has arguably created a handful of extremely attractive bargains.
Canada’s third largest pot cultivator, Aphria (TSX: APHA) (NYSE: APHA), and U.S.-based pure hemp play Charlotte’s Web (TSX: CWEB) (OTCQX: CWBHF) could both prove to be stellar growth vehicles over the next 12 months.
Industry bellwethers Canopy Growth (TSX: WEED) (NYSE: CGC) and Aurora Cannabis (TSX: ACB) (NYSE: ACB) produced bullish reversal chart candles on Wednesday indicating the market could finally be ready to reverse its downtrend.
Pot stocks need to extend the bounce if there is any chance of a full-on reversal. Leading the way were these 10 cannabis stocks.
While the current market is challenging and could see additional pressure over the next few months, we think this is a great time for long-term investors to consider the sector.
For years, we have struggled with the valuations, but they look better than ever with some leaders trading at reasonable multiples of sales or projected EBITDA.
These 3 attractively valued marijuana stocks are currently trading at a fraction of their Wall Street consensus price targets.
Should the market rebound and these targets are reached, four-bagger ROIs become very realistic.
Despite the current ‘Vape Crisis’ sell-off, leading analysts expect these 7 cannabis stocks to outperform moving forward.
“We expect companies that have seen their stock prices decline more than the market average on account of the U.S. crisis are likely to bounce back.”
New analyst ratings, price targets and implied upside from current levels.
The vape crisis continues to blow over as more details emerge.
These vape related marijuana stocks could offer investors decent upside as the market recalibrates.
- Ancillary Vape Plays
- Vape Stocks that Touch the Plant
- Extraction Stocks
Move Over Curaleaf, There’s a New MSO in Town and it’s Set to Hit The Street Soon
Get the full details here so you don’t miss out on the next potential 10 bagger.